EAC pharmaceutical manufacturing
| dc.contributor.author | East African Community | |
| dc.date.accessioned | 2023-07-31T14:03:40Z | |
| dc.date.available | 2023-07-31T14:03:40Z | |
| dc.date.issued | 2022 | |
| dc.description | Policy brief | |
| dc.description.abstract | The pharmaceutical manufacturing landscape in East Africa is rapidly transforming with an estimated market size of USD 3 billion (this is set to be even higher with entry of DRC in to the Community) and Compound Annual Growth Rate (CAGR) of 12%. New investments and expansion of existing facilities are ongoing in all the EAC Partner States. The region is implementing policies and strategies that are aimed at promoting local production of medicines. These include the second EAC Pharmaceutical Manufacturing Plan of Action (EAC RPMPOA 2017-2027) and the Medicines and Health Technologies Policy and Strategic Plan (2016-2021). In addition, the EAC Industrialization Policy and Strategy (2010-2030) has prioritized pharmaceutical manufacturing as one of the six key strategic industries for collective support. All EAC Partner States have established semi-autonomous regulatory agencies. | |
| dc.description.sponsorship | East African Community; Busitema University | |
| dc.identifier.citation | East African Community. (2022). EAC pharmaceutical manufacturing. EAC Secretariat | |
| dc.identifier.uri | https://doi.org/10.60682/6jhp-hb58 | |
| dc.language.iso | en | |
| dc.publisher | EAC Secretariat | |
| dc.title | EAC pharmaceutical manufacturing | |
| dc.type | Other |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- EAC_pharmaceutical_manufacturing_2022
- Size:
- 2.62 MB
- Format:
- Adobe Portable Document Format
- Description:
- Policy brief
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed to upon submission
- Description: